EORTC Scientific strategy meeting 25–26 March 1999

This publication has 33 references indexed in Scilit:

• Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A study of the Leukemia Cooperative Group of the EORTC and GIMEMA
  European Journal Of Cancer, 1999
• Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801
  European Journal Of Cancer, 1998
• Maximal Androgen Blockade: Final Analysis of EORTC Phase III Trial 30853
  European Urology, 1998
• Maximum Androgen Blockade Using LHRH Agonist Buserelin in Combination with Short-Term (Two Weeks) or Long-Term (Continuous) Cyproterone Acetate Is Not Superior to Standard Androgen Deprivation in the Treatment of Advanced Prostate Cancer
  European Urology, 1998
• Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial
  Bone Marrow Transplantation, 1997
• A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer
  Journal of Urology, 1996
• Another Look at Induction Chemotherapy for Organ Preservation in Patients With Head and Neck Cancer
  JNCI Journal of the National Cancer Institute, 1996
• Expression of MAGE genes in primary and metastatic cutaneous melanoma
  International Journal of Cancer, 1995
• The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view
  Critical Reviews in Oncology/Hematology, 1995
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993